Other studies have suggested that the prognosis of mutated RUNX1 AML is context dependent, with worse outcomes observed mainly in patients with ASXL1, SRSF2, and/or PHF6 co‐mutations [12]. This evidence concerns the gene RUNX1 and acute myeloid leukemia.